BioSpace News Archive

Mallinckrodt plc announced it has entered into a definitive agreement to sell its wholly owned subsidiary BioVectra Inc.

The treatment is called GAINSWave®, and is the premium brand of shockwave therapy performed by a highly-trained network of providers across the nation.

DrFirst is first to offer mobile-enabled, real-time document e-signature for patients and providers, protecting patient safety and reducing care delays

VBI Vaccines Inc. announced a collaboration with GlaxoSmithKline (GSK) to clinically evaluate the combination of VBI-1901, VBI’s cancer vaccine immunotherapeutic, with GSK’s proprietary AS01B adjuvant system.

LeafyWell (LeafyWell.com), a subsidiary of NxGen Brands, Inc. (NXGB), today announces uniting with Shari Kaplan Stellino, founder and CEO of Cannectd Biotechnology, (www.Cannectd.com), in offering expert-level input on the creation of new formulations of Cannabidiol (CBD) and especially Cannabigerol (CBG) containing products.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that new data from its Phase 2a Human Challenge Study of EDP-938 will be presented as a late-breaker oral presentation at IDWeek™ 2019, October 2-6, 2019 in Washington, D.C.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today entered into a definitive agreement to acquire Cheetah Medical, a leading provider of non-invasive hemodynamic monitoring technologies.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) today released its second annual Corporate Social Responsibility (CSR) Report.

With infection on the rise in people and pets, pet owners can take steps to protect their dogs

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), today announced that it has selected Clear Dermatology & Aesthetic Center in Scottsdale, AZ as the site for its proof-of-concept (“POC”) clinical trial for the use of its RAP technology for the treatment of keloid and hypertrophic scars